← The Wire
OGNNYSE
Organon & Co.
Pharmaceutical Preparations · CIK 1821825
Organon & Co. develops, manufactures, and markets women's health products, biosimilars, and established medicines
red 8-K · 90d
$3.53B
Market cap
$13.55
Last close
+0.4%
1D
+1.1%
5D
1.4M
Volume
Price · last 39 sessions+2.2%
May 4L $13.26 · H $13.55Jun 29
90
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AJun 11, 2026DEFA14ADEFA14AApr 30, 2026DEFA14ADEFA14AApr 30, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 24, 2026DEFA14ADEFA14AApr 25, 2025DEFA14ADEFA14AApr 25, 2024DEFA14ADEFA14AApr 27, 2023DEFA14ADEFA14AApr 29, 2022
Insider Activity
In the 90 days to Nov 12, 2025: 1 insider bought $502K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2025 | Cox Carrie SmithExecutive Chair | Buy | 65,400 | $7.67 | $502K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance